The consistent expression of TIM-3 and TIGIT across age, sex, and tumor stage suggests their potential utility as broadly applicable checkpoint targets, while the divergent expression patterns of LAG-3 point toward non-redundant, complementary roles within the immunosuppressive tumor microenvironment. The gene discussed is HAVCR2; the disease is neoplasm.